These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24016464)

  • 1. Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial.
    Mills SM; Mallmann J; Santacruz AM; Fuqua A; Carril M; Aisen PS; Althage MC; Belyew S; Benzinger TL; Brooks WS; Buckles VD; Cairns NJ; Clifford D; Danek A; Fagan AM; Farlow M; Fox N; Ghetti B; Goate AM; Heinrichs D; Hornbeck R; Jack C; Jucker M; Klunk WE; Marcus DS; Martins RN; Masters CM; Mayeux R; McDade E; Morris JC; Oliver A; Ringman JM; Rossor MN; Salloway S; Schofield PR; Snider J; Snyder P; Sperling RA; Stewart C; Thomas RG; Xiong C; Bateman RJ
    Rev Neurol (Paris); 2013 Oct; 169(10):737-43. PubMed ID: 24016464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model.
    Bateman RJ; Benzinger TL; Berry S; Clifford DB; Duggan C; Fagan AM; Fanning K; Farlow MR; Hassenstab J; McDade EM; Mills S; Paumier K; Quintana M; Salloway SP; Santacruz A; Schneider LS; Wang G; Xiong C;
    Alzheimers Dement; 2017 Jan; 13(1):8-19. PubMed ID: 27583651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials.
    Liu H; Li J; Ziegemeier E; Adams S; McDade E; Clifford DB; Cao Y; Wang G; Li Y; Mills SL; Santacruz AM; Belyew S; Grill JD; Snider BJ; Mummery CJ; Surti G; Hannequin D; Wallon D; Berman SB; Jimenez-Velazquez IZ; Roberson ED; van Dyck CH; Honig LS; Sanchez-Valle R; Brooks WS; Gauthier S; Galasko D; Masters CL; Brosch J; Hsiung GR; Jayadev S; Formaglio M; Masellis M; Clarnette R; Pariente J; Dubois B; Pasquier F; Bateman RJ; Llibre-Guerra JJ
    J Prev Alzheimers Dis; 2024; 11(3):558-566. PubMed ID: 38706272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).
    Tang M; Ryman DC; McDade E; Jasielec MS; Buckles VD; Cairns NJ; Fagan AM; Goate A; Marcus DS; Xiong C; Allegri RF; Chhatwal JP; Danek A; Farlow MR; Fox NC; Ghetti B; Graff-Radford NR; Laske C; Martins RN; Masters CL; Mayeux RP; Ringman JM; Rossor MN; Salloway SP; Schofield PR; Morris JC; Bateman RJ;
    Lancet Neurol; 2016 Dec; 15(13):1317-1325. PubMed ID: 27777020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DIAN/DIAN-J/DIAN-TU].
    Shimada H; Shoji M; Ikeuchi T; Suzuki K; Senda M; Ishii K; Matsuda H; Iwata A; Ihara R; Iwatsubo T; Mutoh K; Nakazawa E; Sekijima Y; Mori E; Ikeda M; Ikeda M; Kawakatsu S; Nakanishi A; Hashimoto M; Nunomura A; Matsubara E; Fukui M; Shirato T; Hirai K; Sakamoto M; Fujii H; Mori H
    Brain Nerve; 2017 Jul; 69(7):701-709. PubMed ID: 28739983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset.
    Panza F; Seripa D; Lozupone M; Solfrizzi V; Imbimbo BP; Barulli MR; Tortelli R; Capozzo R; Bisceglia P; Dimitri A; Stallone R; Dibello V; Quaranta N; Daniele A; Bellomo A; Greco A; Logroscino G
    Expert Opin Biol Ther; 2018 Jan; 18(1):25-35. PubMed ID: 29037101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathologic assessment of participants in two multi-center longitudinal observational studies: the Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN).
    Cairns NJ; Perrin RJ; Franklin EE; Carter D; Vincent B; Xie M; Bateman RJ; Benzinger T; Friedrichsen K; Brooks WS; Halliday GM; McLean C; Ghetti B; Morris JC; ;
    Neuropathology; 2015 Aug; 35(4):390-400. PubMed ID: 25964057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominantly Inherited Alzheimer Network: facilitating research and clinical trials.
    Moulder KL; Snider BJ; Mills SL; Buckles VD; Santacruz AM; Bateman RJ; Morris JC
    Alzheimers Res Ther; 2013; 5(5):48. PubMed ID: 24131566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance and progress of DIAN/A4/API].
    Shimada H
    Nihon Rinsho; 2016 Mar; 74(3):417-22. PubMed ID: 27025079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer's disease.
    Wang G; Berry S; Xiong C; Hassenstab J; Quintana M; McDade EM; Delmar P; Vestrucci M; Sethuraman G; Bateman RJ;
    Stat Med; 2018 Sep; 37(21):3047-3055. PubMed ID: 29761523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Anti-β-amyloid Monoclonal Antibodies Work in Autosomal Dominant Alzheimer Disease?
    Imbimbo BP; Lucca U; Watling M
    Neurol Genet; 2021 Feb; 7(1):e535. PubMed ID: 33575481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platform Trials to Expedite Drug Development in Alzheimer's Disease: A Report from the EU/US CTAD Task Force.
    Aisen PS; Bateman RJ; Carrillo M; Doody R; Johnson K; Sims JR; Sperling R; Vellas B
    J Prev Alzheimers Dis; 2021; 8(3):306-312. PubMed ID: 34101788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN).
    McKay NS; Gordon BA; Hornbeck RC; Dincer A; Flores S; Keefe SJ; Joseph-Mathurin N; Jack CR; Koeppe R; Millar PR; Ances BM; Chen CD; Daniels A; Hobbs DA; Jackson K; Koudelis D; Massoumzadeh P; McCullough A; Nickels ML; Rahmani F; Swisher L; Wang Q; Allegri RF; Berman SB; Brickman AM; Brooks WS; Cash DM; Chhatwal JP; Day GS; Farlow MR; la Fougère C; Fox NC; Fulham M; Ghetti B; Graff-Radford N; Ikeuchi T; Klunk W; Lee JH; Levin J; Martins R; Masters CL; McConathy J; Mori H; Noble JM; Reischl G; Rowe C; Salloway S; Sanchez-Valle R; Schofield PR; Shimada H; Shoji M; Su Y; Suzuki K; Vöglein J; Yakushev I; Cruchaga C; Hassenstab J; Karch C; McDade E; Perrin RJ; Xiong C; Morris JC; Bateman RJ; Benzinger TLS;
    Nat Neurosci; 2023 Aug; 26(8):1449-1460. PubMed ID: 37429916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease.
    Wang G; Li Y; Xiong C; Benzinger TLS; Gordon BA; Hassenstab J; Aschenbrenner AJ; McDade E; Clifford DB; Libre-Guerra JJ; Shi X; Mummery CJ; van Dyck CH; Lah JJ; Honig LS; Day G; Ringman JM; Brooks WS; Fox NC; Suzuki K; Levin J; Jucker M; Delmar P; Bittner T; Bateman RJ;
    Alzheimers Dement; 2024 Apr; 20(4):2698-2706. PubMed ID: 38400532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the Alzheimer's Disease Neuroimaging Initiative in establishing the Dominantly Inherited Alzheimer Network.
    Morris JC; Buckles VD
    Alzheimers Dement; 2024 Aug; 20(8):5789-5791. PubMed ID: 38958563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group.
    Su Y; Blazey TM; Owen CJ; Christensen JJ; Friedrichsen K; Joseph-Mathurin N; Wang Q; Hornbeck RC; Ances BM; Snyder AZ; Cash LA; Koeppe RA; Klunk WE; Galasko D; Brickman AM; McDade E; Ringman JM; Thompson PM; Saykin AJ; Ghetti B; Sperling RA; Johnson KA; Salloway SP; Schofield PR; Masters CL; Villemagne VL; Fox NC; Förster S; Chen K; Reiman EM; Xiong C; Marcus DS; Weiner MW; Morris JC; Bateman RJ; Benzinger TL;
    PLoS One; 2016; 11(3):e0152082. PubMed ID: 27010959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid beta peptide immunotherapy in Alzheimer disease.
    Delrieu J; Ousset PJ; Voisin T; Vellas B
    Rev Neurol (Paris); 2014 Dec; 170(12):739-48. PubMed ID: 25459121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network.
    Morris JC; Aisen PS; Bateman RJ; Benzinger TL; Cairns NJ; Fagan AM; Ghetti B; Goate AM; Holtzman DM; Klunk WE; McDade E; Marcus DS; Martins RN; Masters CL; Mayeux R; Oliver A; Quaid K; Ringman JM; Rossor MN; Salloway S; Schofield PR; Selsor NJ; Sperling RA; Weiner MW; Xiong C; Moulder KL; Buckles VD
    Clin Investig (Lond); 2012 Oct; 2(10):975-984. PubMed ID: 23139856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A conceptual framework and ethics analysis for prevention trials of Alzheimer Disease.
    Peters KR; Lynn Beattie B; Feldman HH; Illes J
    Prog Neurobiol; 2013 Nov; 110():114-23. PubMed ID: 23348495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging biomarkers in preclinical autosomal dominant Alzheimer's disease by estimated years to symptom onset.
    Wang G; Coble D; McDade EM; Hassenstab J; Fagan AM; Benzinger TLS; Bateman RJ; Morris JC; Xiong C;
    Alzheimers Dement; 2019 Apr; 15(4):506-514. PubMed ID: 30773445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.